PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “TETRAZOLIUM COMPOUNDS”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 73 records · Page 4Linked to original sources
PubMed1982

Studies on the interaction of bleomycin A2 with rat lung microsomes. II. Involvement of adventitious iron and reactive oxygen in bleomycin-mediated DNA chain breakage.

Bleomycin-dependent DNA chain breakage catalyzed by rat lung microsomes and NADPH was significantly inhibited by the reactive oxygen scavengers superoxide dismutase and dimethylurea and by the metal chelator EDTA. Cytochrome c and nitro blue tetrazolium, compounds which interfere with microsomal electron transport, also inhibited bleomycin-mediated DNA chain breakage. In contrast to these agents, ascorbic acid significantly enhanced this bleomycin-mediated reaction. In addition to ascorbic acid, the redox cycling compounds paraquat, nitrofurantoin and mitomycin C also significantly increased the DNA damage by bleomycin. The stimulatory action of these redox cycling compounds was significantly inhibited by superoxide dismutase, demonstrating that reactive oxygen generated by the redox cycling of these compounds was diverted to the bleomycin-DNA complex. These collective observations support the concept that oxidation/reduction of adventitious iron bound by bleomycin and accompanying reactive oxygen generation participate in the microsome-catalyzed DNA damage mediated by bleomycin.

Animals↗
PubMed1998

Immortalized mouse odontoblast cell line MO6-G3 application for in vitro biocompatibility testing.

PURPOSE: This study was designed to determine the usefulness of an established stable immortalized mouse odontoblast cell line (MO6-G3) for dental material biocompatibility testing. Using a standard toxicity assay based on cell respiratory activity, the response to MO6-G3 cells was compared to the mouse fibroblastic cell line, L929, presently used for dental materials testing. The dental resin monomer TEGDMA was used as the dental material for the assay. MATERIALS AND METHODS: Cell lines (1 x 10(3)/well) were plated in 96 well culture plates and grown in DMEM supplemented with 10% FCS, 100 units/ml each of penicillin and streptomycin, and 50 micrograms/ml ascorbic acid in an atmosphere of 95% air and 5% CO2. Cells were exposed to TEGDMA resin monomer covering a dose range of 1 x 10(-6) to 0.5 x 10(-3) M. Unexposed control cells, as well as cells exposed to the DMSO vehicle in which the TEGDMA was dissolved, were included in all assays. Cytotoxicity was evaluated by determining cell respiratory activity spectrophotometrically using the tetrazolium compound WST-1. RESULTS: Statistical analysis by ANOVA using Tukey's method for pair wise comparisons as the post hoc test indicated toxic effects of TEGDMA at 1 x 10(-5) M in the odontoblast cell line MO6-G3. By contrast, the monomer produced no toxic effects on the L929 fibroblast cell line after 24 hours of exposure, over the entire concentration range tested. Furthermore, MO6-G3 cells exposed to a concentration of 0.5 x 10(-3) M were unable to recover from the effects of the exposure 48 hours after removal of the resin. MO6-G3 cells exposed to 1 x 10(-4) and 0.5 x 10(-4) TEGDMA recovered 40-50% and 75-80% of control respiratory activity respectively, 48 hours after removal of the resin. Respiratory activity by L929 cells exposed to all TEGDMA concentrations tested was not different from the vehicle control 48 hours after removal of the resin.

Analysis of Variance↗
PubMed1988

Growth factor effects on small cell lung cancer cells using a colorimetric assay: can a transferrin-like factor mediate autocrine growth?

A semiautomated colorimetric assay (MTT assay), based on the ability of live cells to reduce a tetrazolium-based compound, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT), to a purplish colored formazan product that can be measured spectrophotometrically, has recently been adapted for use in drug sensitivity analysis of cultured human tumor cell lines. We report the application of this assay for the evaluation of the growth factor requirements of human small cell lung cancer (SCLC) cell lines. Specifically, the growth stimulation of each constituent of a previously reported serum-free defined medium system for SCLC including various concentrations of hydrocortisone, insulin, transferrin, 17 beta-estradiol, and selenium (HITES) was evaluated. The optimal concentrations for insulin, transferrin, and selenium derived in the previously reported experiments with direct counting of viable cells were similar to optimal concentrations determined for the growth of three SCLC cell lines (NCI-H82, NCI-N417, NCI-H526) using the MTT assay. In contrast to the previous report, the growth-stimulating effects of hydrocortisone and 17 beta-estradiol were negligible. Using the MTT we have shown that a SCLC cell line, NCI-H345 (which has been previously reported to produce a transferrin-like molecule), was growth-inhibited by an anti-transferrin receptor antibody, when grown in transferrin-free media. The conditioned media from this cell line is stimulatory to other transferrin-sensitive cell lines, suggesting the possibility of an autocrine role for this transferrin-like molecule at least in that cell line. With carefully defined conditions for a given cell line in which cell density and other parameters are within a range of constant MTT metabolism, the assay is well suited for precise analysis of growth factor effects.

Carcinoma, Small Cell↗
PubMed1991

Modified tetrazolium-based colorimetric method for determining the activities of anti-HIV compounds.

A modified tetrazolium-based colorimetric assay was used to determine the anti-HIV activities of ddAzThd, ddCyd, ddIno, and PFA. In this assay, poly-1-lysine-coated plates were used to attach the MT-2 cells to the bottom of the plates. A fixed amount of virus (50 TCID50) was used in each well. A modified version of the formula published by Pauwels et al. (1988) was used for calculating the percentage cell protection from virus infection. Using CC10/EC90 to calculate the selective indices, the decreasing order of selectivity against HIV-1 strain A87SF, was: ddAzThd greater than PFA greater than ddCyd greater than ddIno. Against HIV-1 strain A79SK-1 the decreasing order of selectivity was: PFA greater than ddIno greater than AzThd greater than ddCyd. The modified formula showed lack of anti-HIV activity for thymidine at non-toxic concentrations.

Antiviral Agents↗